Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
The broader signal is that AI is moving from demos into budgets, rules, security procedures and capital allocation.
Sources: BusinessWire; BioSpace; Precision Medicine Online; CocoLoop, CocoLoop.